av/aikido-pharma--big.svg

NASDAQ:AIKI

AIkido Pharma Inc.

  • Stock

USD

Last Close

3.53

22/12 05:00

Market Cap

19.53M

Beta: -

Volume Today

31.93K

Avg: 35.26K

PE Ratio

−0.83

PFCF: −1.76

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
average payables
240K
-
499K
107.92%
556K
11.42%
253.50K
54.41%
89.50K
64.69%
94K
5.03%
100K
6.38%
317.50K
217.50%
283.50K
10.71%
average receivables
1.71K
-
book value per share
50.35K
-
3.73K
92.60%
373.33
89.98%
103.84
72.19%
53.56
48.42%
108.47
102.51%
71.29
34.28%
17.93
74.84%
61.52
243.02%
13.83
77.52%
capex per share
-2.08K
-
-69.83
96.65%
-0.09
99.88%
-0.08
8.47%
-0.32
-
-2.44
654.92%
-0.89
63.49%
capex to depreciation
-6.87
-
-0.10
98.51%
-0.00
99.69%
-0.00
491.02%
-0.02
-
capex to operating cash flow
0.38
-
0.11
72.20%
0.00
99.59%
-0.06
13,300%
0.01
-
0.12
804.54%
0.37
206.17%
capex to revenue
-74.07
-
-100.40
35.54%
-0.06
99.94%
-0.00
92.47%
-1.29
-
-40
3,011.11%
cash per share
3.26K
-
299.42
90.81%
150.78
49.64%
120.26
20.24%
54.72
54.50%
24.36
55.48%
6.42
73.66%
16.66
159.67%
46.62
179.80%
7.56
83.79%
days of inventory on hand
days payables outstanding
32.85K
-
days sales outstanding
debt to assets
0.31
-
0.12
59.87%
0.36
191.60%
0.53
46.36%
0.54
2.64%
0.09
83.96%
0.07
23.60%
0.03
56.74%
0.01
64.06%
0.00
89.59%
debt to equity
0.45
-
0.14
68.33%
0.57
299.86%
1.12
98.31%
1.19
5.76%
0.10
91.96%
0.07
25.28%
0.03
58.42%
0.01
64.73%
0.00
89.36%
dividend yield
earnings yield
-1.69
-
-1.43
15.37%
-10.92
663.33%
-1.68
84.61%
-0.43
74.67%
0.33
178.11%
-1.26
479.32%
-0.50
60.13%
-0.44
13.50%
-1.57
261.46%
enterprise value
7.50M
-
21.12M
181.46%
4.98M
76.43%
3.95M
20.73%
7.61M
92.98%
5.17M
32.04%
3.22M
37.69%
21.81M
576.36%
-49.08M
325.07%
-14.10M
71.27%
enterprise value over ebitda
-0.42
-
-1.02
140.30%
-0.11
89.19%
-0.91
724.97%
-3.95
333.75%
1.63
141.38%
-0.77
147.22%
-1.77
129.33%
6.84
487.21%
0.98
85.64%
ev to operating cash flow
-1.42
-
-2.22
55.87%
-1.08
51.45%
56.37
5,331.69%
-2.33
104.13%
-1.90
18.52%
-1.07
43.64%
-5.42
407.48%
7.43
237.06%
1.33
82.10%
ev to sales
277.89
-
2.11K
659.94%
150.85
92.86%
4.50
97.02%
6.16
36.93%
184.82
2,899.93%
358.25
93.84%
free cash flow per share
-7.58K
-
-731.69
90.34%
-197.21
73.05%
1.29
100.65%
-42.68
3,411.95%
-24.79
41.92%
-22.86
7.80%
-3.32
85.46%
-4.00
20.27%
-1.99
50.31%
free cash flow yield
-0.68
-
-0.49
27.94%
-0.98
98.96%
0.02
101.75%
-0.42
2,560.31%
-0.53
26.36%
-1.02
91.27%
-0.22
78.02%
-0.40
78.98%
-0.56
39.28%
graham net net
-19.21K
-
-227.23
98.82%
-60.16
73.52%
3.91
106.49%
-8.75
324.13%
14.02
260.20%
1.34
90.44%
16.13
1,103.63%
45.98
185.03%
7.09
84.57%
graham number
145.65K
-
13.34K
90.84%
4.29K
67.82%
543.56
87.34%
227.98
58.06%
194.40
14.73%
213.11
9.62%
54.91
74.24%
77.53
41.20%
41.74
46.16%
income quality
0.29
-
0.31
6.25%
0.09
71.20%
-0.01
112.04%
0.99
9,256.28%
-1.58
259.66%
0.72
145.64%
0.33
54.81%
0.92
182.51%
0.48
47.94%
intangibles to total assets
0.95
-
0.93
2.66%
0.72
22.84%
0.44
38.65%
0.40
9.17%
0
100%
0
0
0
0
interest coverage
-1.85
-
interest debt per share
40.34
-
17.37
56.95%
4.43
74.47%
0.63
85.87%
1.47
-
inventory turnover
invested capital
0.01
-
0.05
329.74%
0.04
8.23%
0.01
72.61%
0.00
-
market cap
10.63M
-
21.34M
100.82%
4.71M
77.92%
3.85M
18.25%
7.76M
101.50%
5.19M
33.13%
3.32M
36.15%
24.52M
639.69%
16.48M
32.80%
18.99M
15.23%
net current asset value
-18.27M
-
-3.16M
82.71%
-1.08M
65.82%
335K
131.02%
-521K
255.52%
1.75M
436.28%
379K
78.37%
26.85M
6,985.49%
89.83M
234.51%
48.19M
46.36%
net debt to ebitda
0.18
-
0.01
93.85%
-0.01
154.00%
-0.02
265.24%
0.08
460.11%
-0.01
106.95%
0.02
505.66%
0.22
911.60%
9.14
4,054.44%
2.31
74.77%
net income per share
-18.73K
-
-2.12K
88.66%
-2.20K
3.40%
-126.45
94.24%
-43.13
65.90%
15.48
135.90%
-28.31
282.85%
-7.47
73.61%
-4.34
41.87%
-5.60
28.95%
operating cash flow per share
-5.49K
-
-661.86
87.95%
-197.12
70.22%
1.37
100.69%
-42.68
3,222.70%
-24.47
42.67%
-20.42
16.54%
-2.43
88.08%
-4.00
64.21%
-1.99
50.31%
payables turnover
0.01
-
receivables turnover
research and ddevelopement to revenue
0.37
-
280.22
-
return on tangible assets
-5.43
-
-6.87
26.49%
-13.21
92.23%
-1.02
92.25%
-0.61
40.13%
0.13
121.26%
-0.37
384.48%
-0.40
9.11%
-0.07
82.73%
-0.39
460.86%
revenue per share
28.14
-
0.70
97.53%
1.41
102.44%
17.12
1,116.25%
16.12
5.85%
0.25
98.44%
0.06
75.73%
roe
-0.37
-
-0.57
53.19%
-5.88
932.29%
-1.22
79.30%
-0.81
33.88%
0.14
117.73%
-0.40
378.23%
-0.42
4.88%
-0.07
83.05%
-0.40
473.64%
roic
-0.24
-
-0.52
114.76%
-3.99
667.23%
-0.79
80.33%
-0.45
42.90%
-0.53
17.13%
-0.52
1.91%
-0.27
48.15%
0.33
224.11%
-0.26
179.05%
sales general and administrative to revenue
558.15
-
2.08K
272.48%
155.33
92.53%
5.22
96.64%
2.98
42.91%
109.14
3,560.80%
shareholders equity per share
50.35K
-
3.73K
92.60%
373.33
89.98%
103.84
72.19%
53.56
48.42%
108.47
102.51%
71.29
34.28%
17.93
74.84%
61.52
243.02%
13.83
77.52%
stock based compensation to revenue
369.30
-
1.27K
243.25%
11.24
99.11%
0.64
94.30%
0.02
97.10%
11.43
61,316.15%
36.56
219.86%
tangible asset value
-18.25M
-
-3.13M
82.84%
-1.05M
66.49%
367K
134.99%
528K
43.87%
12.10M
2,191.29%
10.53M
12.94%
29.62M
181.22%
101.59M
243.02%
73.77M
27.39%
tangible book value per share
-19.02K
-
-217.70
98.86%
-44.76
79.44%
7.17
116.01%
6.89
3.89%
108.47
1,474.86%
71.29
34.28%
17.93
74.84%
61.52
243.02%
13.83
77.52%
working capital
1.77M
-
3.18M
79.47%
-592K
118.60%
3.62M
712.16%
1.77M
51.24%
1.75M
0.85%
379K
78.37%
26.85M
6,985.49%
89.83M
234.51%
48.87M
45.60%

All numbers in USD (except ratios and percentages)